9-substituted-8-oxoadenine compound
Abstract
THE PRESENT INVENTION PROVIDES AN 8-OXOADENINE COMPOUND HAVING IMMUNEMODULATING ACTIVITIES SUCH AS AN INTERFERON INDUCING ACTIVITY AND USEFUL AS AN ANTIVIRAL AGENT AND ANTIALLERGIC AGENT, WHICH IS REPRESENTED BY THE FOLLOWING FORMULA (1): [WHEREIN THE RING A REPRESENTS A 6-10 MEMBERED AROMATIC CARBOCYCLIC RING AND THE LIKE, R REPRESENTS A HALOGEN ATOM, AN ALKYL GROUP AND THE LIKE, N REPRESENTS AN INTEGER OF 0-2, Z? REPRESENTS ALKYLENE, X? REPRESENT S OXYGEN ATOM, SULFUR ATOM, SO?, NR?, CO, CONR?, NR?CO AND THE LIKE, Y?, Y? AND Y? REPRESENT INDEPENDENTLY A SINGLE BOND OR AN ALKYLENE GROUP, X? REPRESENTS OXYGEN ATOM, SULFUR ATOM, NR? (R? IS HYDROGEN ATOM OR AN ALKYL GROUP) OR A SINGLE BOND, R? REPRESENTS A SUBSTITUTED OR UNSUBSTITUTED ALKYL GROUP, R? REPRESENTS HYDROGEN ATOM, HYDROXY GROUP, AN ALKOXY GROUP, AN ALKOXYCARBONYL GROUP OR A HALOALKYL GROUP]OR ITS PHARMACOLOGICALLY ACCEPTABLE SALT.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
Every citation, both ways
| Document | Relation | Office |
|---|---|---|
| WO2002004449A | Cites | World Intellectual Property Organization (WIPO) |
| WO1999028321A | Cites | World Intellectual Property Organization (WIPO) |
40 members in 20 offices
Priority claims5
| Document | Office | Kind | Date |
|---|---|---|---|
| 2004093672 | Japan | – | |
| 2004093672 | Japan | A | |
| 2004093672 | Japan | A | |
| 2004093672 | – | – | – |
| JP20040093672 | – | – | – |
Members40
| Document | Office | Kind | |
|---|---|---|---|
| AU2005226359A1 | Australia | A1 | |
| CA2559036A1 | Canada | A1 | |
| WO2005092893A1 | World Intellectual Property Organization (WIPO) | A1 | |
| TW200602345A | Taiwan Province of China | A | |
| NO20064857L | Norway | L | |
| EP1728793A1 | European Patent Office (EPO) | A1 | |
| IL177518A0 | Israel | A0 | |
| KR20070004772A | Republic of Korea | A | |
| CN1938307A | China | A | |
| MXPA06011080A | Mexico | A | |
| HK1098140A1 | Hong Kong, China | A1 | |
| ZA200607574B | South Africa | B | |
| US2007190071A1 | United States of America | A1 | |
| BRPI0509258A | Brazil | A | |
| JPWO2005092893A1 | Japan | A1 | |
| RU2006137706A | Russian Federation | A | |
| UA86798C2 | Ukraine | C2 | |
| JP2010018623A | Japan | A | |
| EP1728793A4 | European Patent Office (EPO) | A4 | |
| NZ549903A | New Zealand | A | |
| JP4472693B2 | Japan | B2 | |
| CN1938307B | China | B | |
| RU2397171C2 | Russian Federation | C2 | |
| AU2005226359B2 | Australia | B2 | |
| IL177518A | Israel | A | |
| US8012964B2 | United States of America | B2 | |
| US2011306610A1 | United States of America | A1 | |
| KR101217303B1 | Republic of Korea | B1 | |
| TW201302753A | Taiwan Province of China | A | |
| TWI392678B | Taiwan Province of China | B | |
| JP5197539B2 | Japan | B2 | |
| MY148686AThis record | Malaysia | A | |
| CA2559036C | Canada | C | |
| US8575180B2 | United States of America | B2 | |
| TWI414525B | Taiwan Province of China | B | |
| US2014045837A1 | United States of America | A1 | |
| US8969362B2 | United States of America | B2 | |
| EP1728793B1 | European Patent Office (EPO) | B1 | |
| ES2563952T3 | Spain | T3 | |
| BRPI0509258A8 | Brazil | A8 |
Numbers
- Publication
- MY-148686-A
- Publication, DOCDB
- 148686
- Publication, EPODOC
- MY148686
- Application
- 1334
- Application, DOCDB
- PI20051334
- Application, EPODOC
- MY2005PI01334
Titles
- English
- 9-SUBSTITUTED-8-OXOADENINE COMPOUND
Classification
- CPC, 12
- C07D473/18
- A61K31/522
- A61K31/5377
- A61P11/06
- A61P17/00
- A61P31/12
- A61P31/22
- A61P35/00
- A61P37/00
- A61P37/02
- A61P37/06
- A61P37/08
- IPC, 7
- C07D473 18
- A61K31 522
- A61K31 5377
- A61P31 12
- A61P35 00
- A61P37 02
- A61P37 08